fda bpc-157 warning not approved human use FDA's Review Of Peptides Signals A Growing Public Health Challenge Is BPC‑157 Legal? WADA, FDA

Neuroinflammation and Brain Injury: It reduces neuroinflammation and supports nerve regeneration, potentially aiding recovery from traumatic brain injuries and protecting against neurodegeneration in conditions like Parkinsons or Alzheimers (though evidence is preliminary)

10 mg bottle $60 GHK-CU in this respect is a strong protector of tissue and an anti-inflammatory agent that prevent the oxidative tissue damage

However, the endothelial damage observed in ME/CFS patients does not appear to correlate with the usual markers of endothelial dysfunction seen in cardiovascular disease such as increased levels of symmetric dimethylarginine (SDMA), asymmetric dimethylarginine (ADMA), and high-sensitivity C-reactive protein (hs-CRP), and reduced levels of arginine and homoarginine (311)

they work in concert

Raju P, Shashikanth N, Tsai PY, Pongkorpsakol P, Chanez-Paredes S, Steinhagen PR, et al